Japanese Translations

Neurology® 2017; Vol. 88

Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Absinta et al. 88(15)1439-1444.

Reduction in time to treatment in prehospital telemedicine evaluation and thrombolysis. Taqui et al. 88(14): 1305-1312.

Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis. Torres-Vega et al. 88(13): 1235-1242.

Postmenopausal hormone therapy and Alzheimer disease: A prospective cohort study. Imtiaz et al. 88(11): 1062-1068.

CADASIL accelerated by acute hypotension: Arterial and venous contribution to leukoaraiosis. Pettersen et al. 88(11): 1077-1080.

Metabolomic biomarkers as strong correlates of Parkinson disease progression. LeWitt et al. 88(9): 862-869.

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Nash et al. 88(9): 842-852.

Burnout, career satisfaction, and well-being among US neurologists in 2016. Busis et al. 88(8): 797-808.

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study. Pedersen et al. 88(8): 767-774.  

Amygdala and hippocampus are symptomatogenic zones for central apneic seizures. Lacuey et al. 88(7): 701-705.

Neuropathology of SUDEP: Role of inflammation, blood-brain barrier impairment, and hypoxia. Michalak et al. 88(6): 551-561.

Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study. Haba-Rubio et al. 88(5): 463-469.

Blood–brain barrier leakage is more widespread in patients with cerebral small vessel disease. Zhang et al. 88(5): 426-432.

Autopsy validation of ¹²³I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Thomas et al. 88(3): 276-283.
 

Neurology® 2009; Vol. 73

Chronic daily headache in adolescents: An 8-year follow-up study, Wang et al. 73(6):416-422

Clinical spectrum of ataxia-telangiectasia in adulthood, Verhagen et al. 73(6):430-437

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET, Shimada et al. 73(4):273-278

Course in Parkinson disease subtypes: A 39-year clinicopathologic study, Rajput et al. 73(3):206-212

Familial aggregation of parkinsonism in progressive supranuclear palsy, Kaat et al. 73(2):98-105

Incidence and prevalence of CIDP and the association of diabetes mellitus, Laughlin et al. 73(1):39-45

 

Neurology® 2009; Vol. 72

Donepezil delays progression to AD in MCI subjects with depressive symptoms, Lu 72(24):2115-2121

MRI lesion profiles in sporadic Creutzfeldt–Jakob disease, Meissner et al. 72(23):1994-2001

Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort, Breitner et al. 72(22):1899-1905

Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALS, Gordon et al. 72(22):1948-1952

Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival, Milionis et al. 72(21):1816-1822

Hypertension and late-life dementia: A real link?, Knopman 72(20):1716-1717

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons, Hoffman et al. 72(20):1720-1726

Duration of antihypertensive drug use and risk of dementia: A prospective cohort study, Haag et al. 72(20):1727-1734

Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial, Yuan et al. 72(17):1473-1478

Quantification of sweat gland innervation: A clinical–pathologic correlation, Gibbons et al. 72(17):1479-1486

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease, Drzezga et al. 72(17):1487-1494

Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS, Kantarci et al. 72(17):1519-1525

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease, Vaillancourt et al. 72(16):1378-1384

Propriospinal myoclonus revisited: Clinical, neurophysiologic, and neuroradiologic findings, Roze et al. 72(15):1301-1309

A mechanism for low penetrance in an ALS family with a novel SOD1 deletion, Zinman et al. 72(13):1153-1159

Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype, van Nuenen et al. 72(12):1041-1047

The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia, Bakkour et al. 72(12):1048-1055

CSF biomarkers in relationship to cognitive profiles in Alzheimer disease, van der Vlies et al. 72(12):1056-1061

Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome, Okuda et al. 72(9):800-805

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders , Magaña 72(8):712-717

Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia, Piguet et al. 72(8):732-737

Idiopathic intracranial hypertension in men, Bruce et al. 72(4):304-309

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil, Moravan and Srgal 72(4):337-340

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy, Johnson et al. 72(3):224-231

A multidisciplinary study of patients with early-onset PD with and without parkin mutations, Lohmann et al. 72(2):110-116

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis, Mitchell 72(1):14-19

Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease, Kalbe et al. 72(1):42-49

Microglial activation and amyloid deposition in mild cognitive impairment: A PET study, Okello et al. 72(1):56-62

 

Neurology® 2008; Vol. 71

Stiff-person syndrome with amphiphysin antibodies: Distinctive features of a rare disease, Murinson and Guarnaccia 71(24):1955-1958

Intensive nutritional supplements can improve outcomes in stroke rehabilitation, Rabadi et al. 71(23):1856-1861

Invited Article: The US health care system: Part 1: Our current system, Nuwer et al. 71(23):1907-1913

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy, Borroni 71(22):1796-1803

Making the lame walk?: Transplantation for POEMS, Chalk 71(21):1658-1659

GM1/GalNAc-GD1a complex: A target for pure motor Guillain-Barré syndrome, Kaida et al. 71(21):1683-1690

Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome, Kuwabara et al. 71(21):1691-1695

The anatomic correlate of prosopagnosia in semantic dementia, Josephs et al. 71(20):1628-1633

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis, Appel et al. 71(17):1326-1334

Warfarin use leads to larger intracerebral hematomas, Flaherty et al. 71(14):1084-1089

Meningeal dissemination in primary CNS lymphoma: Prospective evaluation of 282 patients, Fischer et al. 71(14):1102-1108

Natural history of young-adult amyotrophic lateral sclerosis, Sabatelli et al. 71(12):876-881

Onset of terminal decline in cognitive abilities in individuals without dementia, Thorvaldsson et al. 71(12):882-887

Imaging amyloid deposition in Lewy body diseases, Gomperts et al. 71(12):903-910

Neuronal surface antigen antibodies in limbic encephalitis: Clinical–immunologic associations, Graus et al. 71(12):930-936

Neuropathologic correlates of white matter hyperintensities, Young et al. 71(11):804-811

STN-DBS activates the target area in Parkinson disease: An FDG-PET study, Hilker et al. 71(10):708-713

MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study, Whitwell et al. 71(10):743-749

Denture cream: An unusual source of excess zinc, leading to hypocupremia and neurologic disease, Nations et al. 71(9):639-643

Second consensus statement on the diagnosis of multiple system atrophy, Gilman et al. 71(9):670-676

Carnitine palmitoyltransferase II deficiency: Successful anaplerotic diet therapy, Roe et al. 71(4):260-264

GD1b-specific antibody induces ataxia in Guillain-Barré syndrome, Kaida et al. 71(3):196-201

Fine-tuning gait in Parkinson disease, Tagliati 71(2):76-77

STN-DBS frequency effects on freezing of gait in advanced Parkinson disease, Moreau et al. 71(2):80-84

CNS aquaporin-4 autoimmunity in children, McKeon et al. 71(2):93-100

Late-onset hereditary axonal neuropathies, Bennett et al. 71(1):14-20

 

Neurology® 2008; Vol. 70

Autosomal dominant moyamoya disease maps to chromosome 17q25.3, Mineharu et al. 70(24.2):2357-2363

Primary CNS vasculitis with spinal cord involvement, Salvarani et al. 70(24.2):2394-2400

NMO-IgG predicts the outcome of recurrent optic neuritis, Matiello et al. 70(23):2197-2200

Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology, Arvanitakis et al. 70(23):2219-2225

Longitudinal decline in autopsy-defined frontotemporal lobar degeneration, Grossman et al. 70(22):2036-2045

Seizures in adults with bacterial meningitis, Zoons et al. 70(22.2):2109- 2115

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease, Eberling et al. 70(21):1980-1983

Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy, Medina et al. 70(20.2):2137-2144

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Simpson et al. 70(19):1691-1698

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Simpson et al. 70(19):1699-1706

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Naumann et al. 70(19):1707-1714

Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia, Olichney et al. 70(19.2):1763-1770

CSF biomarkers in frontotemporal lobar degeneration with known pathology, Bian et al. 70(19.2):1827-1835

Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder, Massicotte-Marquez et al. 70(15):1250-1257

A longitudinal study of drivers with Alzheimer disease, Ott et al. 70(14):1171-1178

Predictive markers for response to interferon therapy in patients with multiple sclerosis, Malucchi et al. 70(13.2):1119-1127

Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS, Keegan et al. 70(13.2):1128-1133

SOX1 antibodies are markers of paraneoplastic Lambert–Eaton myasthenic syndrome, Sabater et al. 70(12):924-928

The varicella zoster virus vasculopathies: Clinical, CSF, imaging, and virologic features, Nagel et al. 70(11):853-860

Why do patients with PSP fall?: Evidence for abnormal otolith responses, Liao et al. 70(10):802-809

Deficient sequencing of pantomimes in apraxia, Weiss et al. 70(11):834-840

 

Neurology® 2006; Vol. 67

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease, Kemppainen et al. 67(9):1575-1580

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain, Wernicke et al. 67(8):1411-1420

Corticobasal degeneration and progressive aphasia, McMonagle et al. 67(8):1444-1451

Ten-year risk of dementia in subjects with mild cognitive impairment, Visser et al. 67(7):1201-1207

Dopamine agonists and cardiac valvulopathy in Parkinson disease: A case–control study, Yamamoto et al. 67(7):1225-1229

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS, Kappos et al. 67(6):944-953

Migrainous vertigo: Prevalence and impact on quality of life, Neuhauser et al. 67(6):1028-1033

Efficacy of cabergoline in restless legs syndrome: A placebo-controlled study with polysomnography (CATOR), Oertel et al. 67(6):1040-1046

Noninvasive positive-pressure ventilation in ALS: Predictors of tolerance and survival, Lo Coco et al. 67(5):761-765

Multifocal motor neuropathy with and without conduction block: A single entity?, Delmont et al. 67(4):592-596

CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease, Sanchez-Juan et al. 67(4):637-643

Valosin-containing protein gene mutations: Clinical and neuropathologic features, Guyant-Maréchal et al. 67(4):644-651